Furthermore, MKK3 sustains the epithelial-mesenchymal transition (EMT) and tumor angiogenesis by driving the expression of a specific set of genes [11–15], and supports the malignancy of specific tumor types (as reviewed in [12]). The gene discussed is MAP2K3; the disease is neoplasm.